Clinical Trial

Lifestyle Intervention for Symptoms of Depression wIth App Support in General Practice

Study acronym: LIDIAS
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to find out whether a smartphone app can help reduce symptoms of depression by supporting healthy lifestyle changes and encouraging self-monitoring in adults who visit their general practitioner with symptoms of depression. The main questions this study aims to answer are: Does a personalized lifestyle intervention delivered through the app, in addition to regular care, reduce depression symptoms more effectively than regular care alone? Is this approach more cost-effective than regular care alone? Researchers will compare patients who use the app alongside their regular care to patients who receive regular care without the app, to see whether the app leads to better outcomes. Participants who use the app will: Complete a lifestyle questionnaire focused on six themes: mental wellbeing, use of harmful substances, social relationships, healthy eating, sleep, and physical activity. Set personal goals based on their results and receive tailored lifestyle advice. Track their depression symptoms regularly within the app to support ongoing care. Have follow-up conversations with their general practitioner or mental health nurse to discuss their progress. Fill out questionnaires about their symptoms and experiences during the study.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-06-06; most recent amendment 2025-12-19.
Status change: Not Yet Recruiting → Recruiting 2025-06-17
Trial Details
NCT Number NCT07022184
Lead Sponsor Radboud University Medical Center
Collaborators: Ixta Noa, Hogeschool van Arnhem en Nijmegen (HAN), Pro Persona Mental Health Care Foundation, Amsterdam UMC, Interactive Studios, University Medical Center Groningen
Conditions Depressive/Anxiety Symptoms, Depressive Disorder
Enrollment 216 participants
Start Date 2025-06-17
Primary Completion 2026-11 (estimated)
Study Completion 2027-02 (estimated)
Updated on ClinicalTrials.gov 2025-12-22